Ipsen Biopharm Ltd
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United Kingdom
- Registered address
- Unit 9 Ash Road Wrexham Industrial Estate, Wrexham, LL 13 9UF, United Kingdom (GBR)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 1000346340 · DUNS 365113203
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-05-22
- VAIDrug Quality Assurance2019-04-26
- VAIBlood and Blood Products2018-07-06
- VAIDrug Quality Assurance2017-09-12
- VAIBlood and Blood Products2016-01-20
- VAIDrug Quality Assurance2014-07-08
- VAIDrug Quality Assurance2012-09-18
- NAIDrug Quality Assurance2010-07-12
Drugs this plant is listed as making
1 distinct drugs across 3 products name this site in their FDA label.
- Botulinum Toxin Type AIpsen Biopharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.